NEW YORK (GenomeWeb News) – Allergan announced late on Friday that the US Food and Drug Administration has approved its in vitro, cell-based assay for use in the stability and potency testing of Botox and Botox Cosmetic, possibly eliminating the need for animal-based testing of the treatment.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.